Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IBM vs GSK✓SelectedUSD · GSKIBM vs GSK performance historyLatest closeAs of-1.87%11/16
Stock and ETF performance explorer

IBM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+73.0%
GSK return
+64.4%
Excess return
+8.6%
Maximum drawdown
-37.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.9%-0.1%-1.8%-1.9%
7D-0.8%-1.3%+0.5%-0.6%
30D+5.2%+2.7%+2.5%+4.7%
3M+4.2%+2.7%+1.5%+3.7%
6M+12.1%+3.3%+8.8%+11.8%
YTD-15.9%+6.5%-22.3%-16.7%
1Y-18.5%+10.7%-29.2%-19.7%
3Y+73.0%+64.4%+8.7%+64.8%
All+73.0%+64.4%+8.6%+64.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling